close
read more
Our company
Governance
Global presence
Key figures
Story
Vocation and values
Culture
Financial Results
Servier Institute
Our Products
Servier medicines
Generic drugs
e-Health solutions
Fight against counterfeiting
Areas of expertise
Research & Development
Research Axes
Development portfolio
Clinical trials
Paediatric expertise
Regulatory affairs
Pharmacovigilance
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Business development & licensing
Cross-functional activities
Our commitments
Patient In
Ethics
Compliance policy
CSR approach
Supplier relationship
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate documents
Medical publishing
FR
MEDIATOR INFORMATION
Press
News
Press
02 / 08 / 2019
Press Release of 6 july 2018
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
No
Read more